Proposed Definitions of Typical Lesions in Hidradenitis Suppurativa.


Journal

Dermatology (Basel, Switzerland)
ISSN: 1421-9832
Titre abrégé: Dermatology
Pays: Switzerland
ID NLM: 9203244

Informations de publication

Date de publication:
2020
Historique:
received: 17 07 2019
accepted: 19 03 2020
pubmed: 10 6 2020
medline: 20 7 2021
entrez: 10 6 2020
Statut: ppublish

Résumé

Although not rare, hidradenitis suppurativa (HS) is often under-recognized by physicians. The diagnosis of HS is clinical via the recognition of lesions typical of the disease, but universally accepted definitions of these latter are currently lacking, which means that certain severity scores employed for HS classification/management are used differently by different physicians. Our aim was to develop a set of descriptive definitions and associated images of HS lesions, in order to enable doctors to better recognize and evaluate the disease. MEDLINE-available literature and dermatological textbooks on HS morphology were retrieved (January 1996 to February 2016). A preliminary set of definitions of HS typical lesions was created, including 10 terms. Each term was associated with a pathophysiological classification and an image. This preliminary set was shown during the 5th Conference of the European HS Foundation (EHSF). The physicians attending the event were invited to vote on each term and make comments via a voting sheet. A total of 81 physicians answered the questionnaire. Their agreement/disagreement rates and comments were used to obtain a revised set of definitions and images. Pathophysiological classifications were dropped. A user-friendly set of definitions/images of HS typical lesions was proposed and will need to be validated by further studies. This set could ultimately serve as a tool to better recognize, score, and assess treatment efficacy.

Sections du résumé

BACKGROUND BACKGROUND
Although not rare, hidradenitis suppurativa (HS) is often under-recognized by physicians. The diagnosis of HS is clinical via the recognition of lesions typical of the disease, but universally accepted definitions of these latter are currently lacking, which means that certain severity scores employed for HS classification/management are used differently by different physicians. Our aim was to develop a set of descriptive definitions and associated images of HS lesions, in order to enable doctors to better recognize and evaluate the disease.
METHODS METHODS
MEDLINE-available literature and dermatological textbooks on HS morphology were retrieved (January 1996 to February 2016). A preliminary set of definitions of HS typical lesions was created, including 10 terms. Each term was associated with a pathophysiological classification and an image. This preliminary set was shown during the 5th Conference of the European HS Foundation (EHSF). The physicians attending the event were invited to vote on each term and make comments via a voting sheet.
RESULTS RESULTS
A total of 81 physicians answered the questionnaire. Their agreement/disagreement rates and comments were used to obtain a revised set of definitions and images. Pathophysiological classifications were dropped.
CONCLUSION CONCLUSIONS
A user-friendly set of definitions/images of HS typical lesions was proposed and will need to be validated by further studies. This set could ultimately serve as a tool to better recognize, score, and assess treatment efficacy.

Identifiants

pubmed: 32516781
pii: 000507348
doi: 10.1159/000507348
doi:

Types de publication

Consensus Development Conference Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-438

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Mathilde Daxhelet (M)

Department of Dermatology, Université Libre de Bruxelles, Erasme Hospital, Brussels, Belgium, daxheletmathilde@gmail.com.

Mariano Suppa (M)

Department of Dermatology, Université Libre de Bruxelles, Erasme Hospital, Brussels, Belgium.

Jonathan White (J)

Department of Dermatology, Université Libre de Bruxelles, Erasme Hospital, Brussels, Belgium.

Farida Benhadou (F)

Department of Dermatology, Université Libre de Bruxelles, Erasme Hospital, Brussels, Belgium.

Linnea Rishøj Thorlacius (LR)

Department of Dermatology, University of Copenhagen, Roskilde Hospital, Copenhagen, Denmark.

Gregor B E Jemec (GBE)

Department of Dermatology, University of Copenhagen, Roskilde Hospital, Copenhagen, Denmark.

Véronique Del Marmol (V)

Department of Dermatology, Université Libre de Bruxelles, Erasme Hospital, Brussels, Belgium.

Jean Revuz (J)

Private practice, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH